Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Lyra Randzavola

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 14, 2026 · JOURNAL ARTICLE

Enhancing iNKT cell immunotherapy through the integration of optimized CAR endodomains and iNKT engagers

Nature Communications

Mechanistic and preclinical study demonstrating CAR-iNKT cell engineering and engager design in vitro and in animal models, without clinical efficacy data or human trials.

PreliminaryLyra Randzavola Hongwei Ren Anastasios Karadimitris

Study details

DesignPreclinical mechanistic study

InterventionFive different CAR endodomains in iNKT cell…

ComparatorCAR-T cells; FCRL5 CAR-iNKT without engager.

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support